Folate Deficiency-Triggered Redox Pathways Confer Drug Resistance in Hepatocellular Carcinoma

Oncotarget - United States
doi 10.18632/oncotarget.4422
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Hedgehog Signalling Mediates Drug Resistance Through Targeting TAP1 in Hepatocellular Carcinoma

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2020English

DEPDC5 Deficiency Contributes to Resistance to Leucine Starvation via P62 Accumulation in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2018English

Acidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-Arterial Drug Delivery to Hepatocellular Carcinoma

ACS Applied Materials & Interfaces
MedicineMaterials ScienceNanotechnologyNanoscience
2016English

Drug-Eluting Beads in Hepatocellular Carcinoma

Therapeutic Advances in Gastroenterology
Gastroenterology
2017English

Effects of Mitochondrial Translocation of Telomerase on Drug Resistance in Hepatocellular Carcinoma Cells

Journal of Cancer
Oncology
2015English

Plasma Folate and Vitamin B12 Levels in Patients With Hepatocellular Carcinoma

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Mutations in the Reduced Folate Carrier Gene Which Confer Dominant Resistance to 5,10-Dideazatetrahydrofolate

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1998English

Signaling Pathways Involved in Molecular Carcinogenesis of Hepatocellular Carcinoma

2012English

AIM2 Deficiency Reduces the Development of Hepatocellular Carcinoma in Mice

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy